Serum biomarker profiles suggest that atopic dermatitis is a systemic disease-Reference-Cited by-同舟云学术

Serum biomarker profiles suggest that atopic dermatitis is a systemic disease

Published:2018-04 Issue:4 Volume:141 Page:1523-1526
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Thijs Judith L.,Strickland Ian,Bruijnzeel-Koomen Carla A.F.M.,Nierkens Stefan,Giovannone Barbara,Knol Edward F.,Csomor Eszter^ORCID,Sellman Bret R.,Mustelin Tomas,Sleeman Matthew A.,de Bruin-Weller Marjolein S.,Herath Athula,Drylewicz Julia,May Richard D.,Hijnen DirkJan^ORCID

Funder

MedImmune

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference9 articles.

1. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder;Brunner;J Invest Dermatol,2017

2. Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis;Andersen;J Allergy Clin Immunol,2016

3. Association of atopic dermatitis with cardiovascular risk factors and diseases;Standl;J Invest Dermatol,2017

4. Assessment of major comorbidities in adults with atopic dermatitis using the Charlson comorbidity index;Thyssen;J Am Acad Dermatol,2017

5. Persistent release of IL-1s from skin is associated with systemic cardio-vascular disease, emaciation and systemic amyloidosis: the potential of anti-IL-1 therapy for systemic inflammatory diseases;Yamanaka;PLoS One,2014

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skin and systemic inflammation in adults with atopic dermatitis before and after whole‐body topical betamethasone 17‐valerate 0.1% or tacrolimus 0.1% treatment: A randomized controlled study;Journal of the European Academy of Dermatology and Venereology;2024-07-30

2. Exploring causal correlations between circulating cytokines and atopic dermatitis: a bidirectional two-sample Mendelian randomization study;Frontiers in Immunology;2024-07-11

3. IL-26 Potentiates Type 2 Skin Inflammation in the Presence of IL-1β;Journal of Investigative Dermatology;2024-07

4. Integrating multi‐omics approaches in deciphering atopic dermatitis pathogenesis and future therapeutic directions;Allergy;2024-06-04

5. Proteomic alterations in patients with atopic dermatitis;Expert Review of Proteomics;2024-05-22